Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
News
History
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts124/v4/26/4d/f3/264df359-df7c-6652-37a5-2b216f0ac72f/mza_14571208827114964829.jpg/600x600bb.jpg
Research Developments in Atopic Dermatitis
Annenberg Center for Health Sciences at Eisenhower
10 episodes
2 days ago
Welcome to this activity focusing on new research related to atopic dermatitis presented as posters at the 2020 virtual annual meetings of the American Academy of Dermatology and the American Academy of Allergy, Asthma, and Immunology. The posters focus on new data related to the use of advanced therapies for atopic dermatitis. Beyond discussing the methods and results of each poster, the faculty, Drs. Steven Feldman and Alan Fleischer, Jr., share their views on the implication of the trial results on clinical practice.
Show more...
Medicine
Health & Fitness
RSS
All content for Research Developments in Atopic Dermatitis is the property of Annenberg Center for Health Sciences at Eisenhower and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to this activity focusing on new research related to atopic dermatitis presented as posters at the 2020 virtual annual meetings of the American Academy of Dermatology and the American Academy of Allergy, Asthma, and Immunology. The posters focus on new data related to the use of advanced therapies for atopic dermatitis. Beyond discussing the methods and results of each poster, the faculty, Drs. Steven Feldman and Alan Fleischer, Jr., share their views on the implication of the trial results on clinical practice.
Show more...
Medicine
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/8538602/8538602-1598631838364-c15bc8d19b632.jpg
Dupilumab Treatment for up to Three Years Demonstrates Sustained Efficacy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Liberty AD Adult Open Label Extension
Research Developments in Atopic Dermatitis
5 minutes 17 seconds
5 years ago
Dupilumab Treatment for up to Three Years Demonstrates Sustained Efficacy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Liberty AD Adult Open Label Extension

This poster was presented by Dr. Blauvelt and colleagues at the 2020 American Academy of Dermatology virtual annual meeting.

This over is provided by Dr. Steve Feldman.

Research Developments in Atopic Dermatitis
Welcome to this activity focusing on new research related to atopic dermatitis presented as posters at the 2020 virtual annual meetings of the American Academy of Dermatology and the American Academy of Allergy, Asthma, and Immunology. The posters focus on new data related to the use of advanced therapies for atopic dermatitis. Beyond discussing the methods and results of each poster, the faculty, Drs. Steven Feldman and Alan Fleischer, Jr., share their views on the implication of the trial results on clinical practice.